(Q58971166)

English

Two-Year Treatment With Denosumab (AMG 162) in a Randomized Phase 2 Study of Postmenopausal Women With Low BMD

scientific article published on 01 December 2007

Statements

Two-year treatment with denosumab (AMG 162) in a randomized phase 2 study of postmenopausal women with low BMD (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit